Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

TriLink BioTechnologies®, a division of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ), announced a non-exclusive ...

Amid a fresh wave of COVID-19, American researchers have now found a news type of mRNA vaccine to prevent the deadly disease.

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

Alzheimer's disease is the most common cause of dementia and affects more than a tenth of Americans aged 65 and older. The ...

Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...

Jon Ellis and Simon Vanstone, PhD, go behind the headlines to explore the latest M&A activity and what tariffs and funding changes could mean for mRNA and beyond.

Like a bunny boiler who refuses to die in a horror movie, the Covid jabs are back. Headlines trumpet the familiar narrative: ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...